Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Fortinet, Inc.FTNT · Entity 2890 | Director | September 30, 2026 | October 02, 2026 |
| Fulgent Genetics, Inc.FLGT · Entity 2545 | Director · Chief Executive Officer · 10% owner | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Fortinet, Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,056 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Exercise / conversion · Acquired 459 · Balance 10,056 F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 12, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,377 |
Reported balance
After 2026-09-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-30 · Exercise / conversion · Disposed 459 · Balance 1,377 F6: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 12, 2026. F7: The RSUs will vest in substantially equal increments on each of September 30, 2026, December 31, 2026, March 31, 2027, and the earlier of (i) June 30, 2027 and (ii) the date immediately preceding the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F8: RSUs do not expire; they either vest or are canceled prior to vest date. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 53,082 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 53,082 F2: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 25 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 25 F3: These securities are held by the Pauline Hsieh Irrevocable Trust dated 05/12/04, of which the Reporting Person is a trustee. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 25 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 25 F4: These securities are held by the Tiffany Hsieh Irrevocable Trust dated 05/12/04, of which the Reporting Person is a trustee. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 143 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 143 F5: These securities are held by the Ming Hsieh Revocable Family Trust, of which the Reporting Person is a trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 12, 2026.
F2: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust.
F3: These securities are held by the Pauline Hsieh Irrevocable Trust dated 05/12/04, of which the Reporting Person is a trustee.
F4: These securities are held by the Tiffany Hsieh Irrevocable Trust dated 05/12/04, of which the Reporting Person is a trustee.
F5: These securities are held by the Ming Hsieh Revocable Family Trust, of which the Reporting Person is a trustee.
F6: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.
F7: The RSUs will vest in substantially equal increments on each of September 30, 2026, December 31, 2026, March 31, 2027, and the earlier of (i) June 30, 2027 and (ii) the date immediately preceding the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting.
F8: RSUs do not expire; they either vest or are canceled prior to vest date.
Fulgent Genetics, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 885,952 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Tax withholding · Disposed 4,392 · Balance 885,952 F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 7,895,115 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 7,895,115 F2: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 220,816 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 220,816 F3: Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectUniform Transfer to Minor Account | 1,000 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,000 F4: Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power. |
| Common StockSEC Table I · non-derivative | IndirectBy Immediate Family | 1,000 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,000 F5: Shares, which were previously held in a Uniform Transfers to Minor Act account, now held by an immediate family member residing in the same household as Ming Hsieh. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.
F2: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust.
F3: Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein.
F4: Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power.
F5: Shares, which were previously held in a Uniform Transfers to Minor Act account, now held by an immediate family member residing in the same household as Ming Hsieh.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2017 Filed Dec 4, 2017 21:04 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 1,000 | $3.60 | $3,604.20 |
DisclosureSEC source: 0001209191-17-063500 · doc4.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · As UTMA Custodian Disclosed balance after: 1,000 F1 · price: The shares were purchased in multiple transactions at prices ranging from $3.58 to $3.63, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · ownership.nature: The shares were purchased by Ming Hsieh as the custodian for his minor child under a Uniform Transfers to Minors Act ("UTMA") account. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 21:04 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 1,000 | $3.60 | $3,604.20 |
DisclosureSEC source: 0001209191-17-063500 · doc4.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · As UTMA Custodian Disclosed balance after: 1,000 F1 · price: The shares were purchased in multiple transactions at prices ranging from $3.58 to $3.63, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · ownership.nature: The shares were purchased by Ming Hsieh as the custodian for his minor child under a Uniform Transfers to Minors Act ("UTMA") account. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 22:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 1,599 | $3.13 | $4,997.35 |
DisclosureSEC source: 0001209191-17-062379 · doc4.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,549,707 F1 · price: The shares were purchased in multiple transactions at prices ranging from $3.01 to $3.22, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 20, 2017 Filed Nov 20, 2017 23:02 UTC | Fortinet, Inc. FTNT · Entity 2890 | SaleCommon Stock | 331 | $40.41 | $13,375.71 |
DisclosureSEC source: 0001140361-17-043409 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 20, 2017 Filed Nov 21, 2017 21:10 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 7,259 | $3.28 | $23,805.89 |
DisclosureSEC source: 0001209191-17-062016 · doc4.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,548,108 F2 · price: The shares were purchased in multiple transactions at prices ranging from $3.20 to $3.34, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 21:10 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 12,291 | $3.16 | $38,861.68 |
DisclosureSEC source: 0001209191-17-062016 · doc4.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,540,849 F1 · price: The shares were purchased in multiple transactions at prices ranging from $3.07 to $3.285, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 21:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 1,905 | $3.22 | $6,136.39 |
DisclosureSEC source: 0001209191-17-061433 · doc4.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,528,558 F2 · price: The shares were purchased in multiple transactions at prices ranging from $3.19 to $3.41, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 300 | $3.28 | $984.99 |
DisclosureSEC source: 0001209191-17-061433 · doc4.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,526,653 F1 · price: The shares were purchased in multiple transactions at prices ranging from $3.27 to $3.30, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 21:07 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 2,800 | $3.35 | $9,374.96 |
DisclosureSEC source: 0001209191-17-060858 · doc4.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,526,353 F2 · price: The shares were purchased in multiple transactions at prices ranging from $3.31 to $3.41, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 21:07 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 7,704 | $3.28 | $25,267.58 |
DisclosureSEC source: 0001209191-17-060858 · doc4.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,523,553 F1 · price: The shares were purchased in multiple transactions at prices ranging from $3.22 to $3.39, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 21:55 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 9,385 | $3.35 | $31,403.15 |
DisclosureSEC source: 0001209191-17-060340 · doc4.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,515,849 F2 · price: The shares were purchased in multiple transactions at prices ranging from $3.22 to $3.43, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:55 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 11,520 | $3.47 | $40,028.54 |
DisclosureSEC source: 0001209191-17-060340 · doc4.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,506,464 F1 · price: The shares were purchased in multiple transactions at prices ranging from $3.35 to $3.53, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:59 UTC | Fortinet, Inc. FTNT · Entity 2890 | GrantRestricted Stock Units · Derivative | 6,021 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-042177 · doc1.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,021 Underlying: Common Stock · 6,021 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: 100% of the RSUs vest on August 9, 2018, subject to the continuing service of the Reporting Person on the vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F4 · derivative.expiration_date: 100% of the RSUs vest on August 9, 2018, subject to the continuing service of the Reporting Person on the vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:59 UTC | Fortinet, Inc. FTNT · Entity 2890 | SaleCommon Stock | 5,332 | $39.64 | $211,377.54 |
DisclosureSEC source: 0001140361-17-042177 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331 F1 · shares: Represents the aggregate of sales effected on the same day at different prices. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $39.30 to $39.655 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 22:24 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 331 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-041449 · doc1.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 994 Underlying: Common Stock · 331 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 6, 2014. F3 · derivative.exercise_date: 25% of the RSUs vested on August 6, 2015, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F3 · derivative.expiration_date: 25% of the RSUs vested on August 6, 2015, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 22:24 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 331 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-041449 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 6, 2014. Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 22:54 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-032366 · doc1.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 11, 2016. F3 · derivative.exercise_date: 100% of the RSUs vested on August 11, 2017. Shares of the Issuer's common stock were delivered to the Reporting Person upon vesting. F3 · derivative.expiration_date: 100% of the RSUs vested on August 11, 2017. Shares of the Issuer's common stock were delivered to the Reporting Person upon vesting. Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 22:54 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-032366 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 11, 2016. Read SEC document |
| August 06, 2017 Filed Aug 8, 2017 21:10 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 332 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-030624 · doc1.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,325 Underlying: Common Stock · 332 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 6, 2014. F3 · derivative.exercise_date: 25% of the RSUs vested on August 6, 2015, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F3 · derivative.expiration_date: 25% of the RSUs vested on August 6, 2015, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| August 06, 2017 Filed Aug 8, 2017 21:10 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 332 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-030624 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 6, 2014. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 22:51 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 12,700 | $5.35 | $67,948.81 |
DisclosureSEC source: 0001209191-17-040258 · doc4.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,494,944 F2 · price: The shares were purchased in multiple transactions at prices ranging from $5.2999 to $5.385, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 22:51 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 7,300 | $5.11 | $37,279.64 |
DisclosureSEC source: 0001209191-17-040258 · doc4.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,482,244 F1 · price: The shares were purchased in multiple transactions at prices ranging from $5.01 to $5.185, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 13, 2017 Filed Jun 14, 2017 00:28 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 15,000 | $5.01 | $75,190.50 |
DisclosureSEC source: 0001209191-17-039732 · doc4.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,474,944 F2 · price: The shares were purchased in multiple transactions at prices ranging from $4.93 to $5.055, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 00:28 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseCommon Stock | 15,000 | $4.95 | $74,205.00 |
DisclosureSEC source: 0001209191-17-039732 · doc4.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,459,944 F1 · price: The shares were purchased in multiple transactions at prices ranging from $4.84 to $5.09, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 21:20 UTC | Fortinet, Inc. FTNT · Entity 2890 | SaleCommon Stock | 4,743 | $39.29 | $186,374.76 |
DisclosureSEC source: 0001140361-17-024598 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents the aggregate of sales effected on the same day at different prices. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $39.29 to $39.295 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 14, 2017 Filed May 16, 2017 21:56 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021036 · doc1.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on May 14, 2013. F3 · derivative.exercise_date: 25% of the RSUs vest on May 14, 2014, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F3 · derivative.expiration_date: 25% of the RSUs vest on May 14, 2014, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| May 14, 2017 Filed May 16, 2017 21:56 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021036 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on May 14, 2013. Read SEC document |
| May 06, 2017 Filed May 9, 2017 00:06 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 331 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-018934 · doc1.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,657 Underlying: Common Stock · 331 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 6, 2014. F3 · derivative.exercise_date: 25% of the RSUs vested on August 6, 2015, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F3 · derivative.expiration_date: 25% of the RSUs vested on August 6, 2015, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| May 06, 2017 Filed May 9, 2017 00:06 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 331 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-018934 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 6, 2014. Read SEC document |
| February 14, 2017 Filed Feb 14, 2017 22:23 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-007408 · doc1.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on May 14, 2013. F3 · derivative.exercise_date: 25% of the RSUs vest on May 14, 2014, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F3 · derivative.expiration_date: 25% of the RSUs vest on May 14, 2014, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| February 14, 2017 Filed Feb 14, 2017 22:23 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-007408 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on May 14, 2013. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 23:17 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 331 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-004949 · doc1.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,988 Underlying: Common Stock · 331 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 6, 2014. F3 · derivative.exercise_date: 25% of the RSUs vested on August 6, 2015, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F3 · derivative.expiration_date: 25% of the RSUs vested on August 6, 2015, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 23:17 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 331 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-004949 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 6, 2014. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:26 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-086802 · doc1.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on May 14, 2013. F3 · derivative.exercise_date: 25% of the RSUs vest on May 14, 2014, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F3 · derivative.expiration_date: 25% of the RSUs vest on May 14, 2014, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:26 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-086802 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on May 14, 2013. Read SEC document |
| November 06, 2016 Filed Nov 8, 2016 23:30 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionRestricted Stock Units · Derivative | 331 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-085441 · doc1.xml · derivative · entry 2 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,319 Underlying: Common Stock · 331 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 6, 2014. F3 · derivative.exercise_date: 25% of the RSUs vested on August 6, 2015, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F3 · derivative.expiration_date: 25% of the RSUs vested on August 6, 2015, then the remaining 75% of the RSUs vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| November 06, 2016 Filed Nov 8, 2016 23:30 UTC | Fortinet, Inc. FTNT · Entity 2890 | Exercise / conversionCommon Stock | 331 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-085441 · doc1.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 6, 2014. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 21:47 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Disposition to issuerPredecessor Class D-1 Preferred Units · Derivative | 10,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-144551 · doc4.xml · derivative · entry 8 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Annuity Trust Disclosed balance after: 0 Underlying: Predecessor Class D Voting Common Units · 10,000,000 shares Expires not disclosed F5 · security: Reflects securities of the Predecessor. Fulgent LLC is considered the predecessor of the Issuer following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the "Reorganization"), which was completed on September 30, 2016 in connection with the Issuer's initial public offering and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all of the Predecessor's Class D-1 preferred units were cancelled in exchange for shares of the Issuer's common stock at a ratio of 7.6-for-1. F7 · derivative.exercise_price: Prior to the Reorganization, the Predecessor's Class D-1 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with an initial public offering of the Predecessor or a successor thereof. F9 · price: The securities were disposed of and cancelled in the Reorganization in exchange for 1,315,789 shares of the Issuer's common stock. F7 · derivative.exercise_date: Prior to the Reorganization, the Predecessor's Class D-1 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with an initial public offering of the Predecessor or a successor thereof. F7 · derivative.expiration_date: Prior to the Reorganization, the Predecessor's Class D-1 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with an initial public offering of the Predecessor or a successor thereof. F5 · derivative.underlying: Reflects securities of the Predecessor. Fulgent LLC is considered the predecessor of the Issuer following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the "Reorganization"), which was completed on September 30, 2016 in connection with the Issuer's initial public offering and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all of the Predecessor's Class D-1 preferred units were cancelled in exchange for shares of the Issuer's common stock at a ratio of 7.6-for-1. F4 · ownership.nature: The securities are held of record by the Ming Hsieh Annuity Trust established May 4, 2016 (the "Annuity Trust"), over which Mr. Hsieh possesses sole voting and dispositive power as the sole trustee. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 21:47 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Disposition to issuerPredecessor Class D-1 Preferred Units · Derivative | 41,381,579 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-144551 · doc4.xml · derivative · entry 7 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Predecessor Class D Voting Common Units · 41,381,579 shares Expires not disclosed F5 · security: Reflects securities of the Predecessor. Fulgent LLC is considered the predecessor of the Issuer following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the "Reorganization"), which was completed on September 30, 2016 in connection with the Issuer's initial public offering and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all of the Predecessor's Class D-1 preferred units were cancelled in exchange for shares of the Issuer's common stock at a ratio of 7.6-for-1. F7 · derivative.exercise_price: Prior to the Reorganization, the Predecessor's Class D-1 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with an initial public offering of the Predecessor or a successor thereof. F8 · price: The securities were disposed of and cancelled in the Reorganization in exchange for 5,444,944 shares of the Issuer's common stock. F7 · derivative.exercise_date: Prior to the Reorganization, the Predecessor's Class D-1 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with an initial public offering of the Predecessor or a successor thereof. F7 · derivative.expiration_date: Prior to the Reorganization, the Predecessor's Class D-1 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with an initial public offering of the Predecessor or a successor thereof. F5 · derivative.underlying: Reflects securities of the Predecessor. Fulgent LLC is considered the predecessor of the Issuer following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the "Reorganization"), which was completed on September 30, 2016 in connection with the Issuer's initial public offering and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all of the Predecessor's Class D-1 preferred units were cancelled in exchange for shares of the Issuer's common stock at a ratio of 7.6-for-1. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 21:47 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | PurchaseIssuer Common Stock | 1,000,000 | $9.00 | $9,000,000.00 |
DisclosureSEC source: 0001209191-16-144551 · doc4.xml · nonDerivative · entry 4 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,444,944 Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 21:47 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantIssuer Common Stock | 1,315,789 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-144551 · doc4.xml · nonDerivative · entry 3 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Annuity Trust Disclosed balance after: 1,315,789 F3 · price: The securities were received in the Reorganization (as defined below) in exchange for the cancellation of 10,000,000 of the Predecessor's Class D-1 preferred units. F4 · ownership.nature: The securities are held of record by the Ming Hsieh Annuity Trust established May 4, 2016 (the "Annuity Trust"), over which Mr. Hsieh possesses sole voting and dispositive power as the sole trustee. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 21:47 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantIssuer Common Stock | 5,444,944 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-144551 · doc4.xml · nonDerivative · entry 2 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,444,944 F2 · price: The securities were received in the Reorganization (as defined below) in exchange for the cancellation of 41,381,579 Class D-1 preferred units of Fulgent Therapeutics LLC (the "Predecessor" or "Fulgent LLC"). F1 · balance_after: Prior to the Reorganization (as defined below), Mr. Hsieh was issued one share of the common stock of Fulgent Genetics, Inc. (the "Issuer") upon the Issuer's formation. In the Reorganization, such share was cancelled and extinguished without any conversion thereof and no payment was made with respect thereto. As a result, such share is not reflected as held or beneficially owned by Mr. Hsieh following the Reorganization. Read SEC document |
| May 13, 2016 Filed Oct 4, 2016 21:47 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SalePredecessor Class D-1 Preferred Units · Derivative | 4,618,421 | $1.17 | $5,389,235.46 |
DisclosureSEC source: 0001209191-16-144551 · doc4.xml · derivative · entry 5 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,381,579 Underlying: Predecessor Class D Voting Common Units · 4,618,421 shares Expires not disclosed F5 · security: Reflects securities of the Predecessor. Fulgent LLC is considered the predecessor of the Issuer following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the "Reorganization"), which was completed on September 30, 2016 in connection with the Issuer's initial public offering and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all of the Predecessor's Class D-1 preferred units were cancelled in exchange for shares of the Issuer's common stock at a ratio of 7.6-for-1. F6 · security: Reflects securities of the Predecessor sold or beneficially owned by Mr. Hsieh as of May 13, 2016. F7 · derivative.exercise_price: Prior to the Reorganization, the Predecessor's Class D-1 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with an initial public offering of the Predecessor or a successor thereof. F7 · derivative.exercise_date: Prior to the Reorganization, the Predecessor's Class D-1 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with an initial public offering of the Predecessor or a successor thereof. F7 · derivative.expiration_date: Prior to the Reorganization, the Predecessor's Class D-1 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with an initial public offering of the Predecessor or a successor thereof. F5 · derivative.underlying: Reflects securities of the Predecessor. Fulgent LLC is considered the predecessor of the Issuer following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the "Reorganization"), which was completed on September 30, 2016 in connection with the Issuer's initial public offering and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all of the Predecessor's Class D-1 preferred units were cancelled in exchange for shares of the Issuer's common stock at a ratio of 7.6-for-1. Read SEC document |
| May 13, 2016 Filed Oct 4, 2016 21:47 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantIssuer Common Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144551 · doc4.xml · nonDerivative · entry 1 Hsieh Ming · CIK 0001302110 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 F1 · balance_after: Prior to the Reorganization (as defined below), Mr. Hsieh was issued one share of the common stock of Fulgent Genetics, Inc. (the "Issuer") upon the Issuer's formation. In the Reorganization, such share was cancelled and extinguished without any conversion thereof and no payment was made with respect thereto. As a result, such share is not reflected as held or beneficially owned by Mr. Hsieh following the Reorganization. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.